Changes in a blood-based molecular pathway identified in Alzheimer’s disease

Researchers identify a molecular bridge between amyloid-β and chronic inflammation, two hallmarks of Alzheimer's. That bridge, a molecular cascade known as the contact system, suggests the possibility of a simple blood test that could diagnose the disease early and non-invasively. More »

Read the whole article on The Rockefeller University

More from The Rockefeller University